Compared to luminal breast cancer subtypes, ZEB1 is highly expressed in triple-negative breast cancers, which express neither ERα nor progesterone receptor (PR), which is encoded by an ERα target gene24,25. This evidence concerns the gene ESR1 and triple-negative breast carcinoma.